[177Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells.
| Publicado en: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 32; no. 12; pp. 1457 - 1463 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Dec2005
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104325254&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 104325254 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 16197070 NPC jtl: European Journal of Nuclear Medicine & Molecular Imaging issn: 16197070 maglogo: N pubinfo: dt: Dec2005 vid: 32 iid: 12 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 104325254 2011946502 10.1007/s00259-005-1902-0 104325254 ppf: 1457 ppct: 6 formats: fmt: @attributes: type: P tig: atl: [177Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells. aug: au: Persson, Mikael Tolmachev, Vladimir Andersson, Karl Gedda, Lars Sandström, Mattias Carlsson, Jörgen affil: Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden; Experimental Urology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|